Petmed Express (PETS) Stock Price

Petmed Express Price

NASDAQ·CLOSED
1.83USD-0.20 (-10.36 %)
Market closed

Revenue has compounded at 0.5% per year over the past 19 years to 179.02 M USD. Earnings per share have declined at 5.4% per year over the last 16 years. Petmed Express's net margin stands at -32.0%, down from 7.7% several years earlier. Petmed Express currently offers a dividend yield of about 32.79%. The payout ratio is around 195% of earnings. The dividend has grown at 7.6% per year over the past 15 years. Analysts set a median price target of 2.81 USD, implying 53.3% above the current price. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus. The stock trades about 14% above its 52-week low.

Petmed Express stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Petmed Express over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Petmed Express stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Petmed Express's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Petmed Express Stock Price History
DatePetmed Express Price
8/14/20261.83 USD
8/13/20262.03 USD
8/12/20262.01 USD
8/11/20261.98 USD
8/10/20261.97 USD
8/7/20261.98 USD
8/6/20261.97 USD
8/5/20261.98 USD
8/4/20261.98 USD
8/3/20261.98 USD
7/31/20261.95 USD
7/30/20261.98 USD
7/29/20261.99 USD
7/27/20261.97 USD
7/23/20262.05 USD
7/22/20261.96 USD
7/21/20261.99 USD
7/20/20261.96 USD
7/17/20261.97 USD
7/16/20262.00 USD
7/15/20262.00 USD
7/14/20261.95 USD
7/13/20261.98 USD
7/10/20261.96 USD
7/9/20261.96 USD
7/8/20261.90 USD
7/7/20261.92 USD
7/6/20261.92 USD
7/2/20261.98 USD
7/1/20261.99 USD
6/30/20261.92 USD
6/29/20261.82 USD
6/26/20261.76 USD
6/25/20261.77 USD
6/24/20261.79 USD
6/23/20261.83 USD
6/22/20261.75 USD
6/18/20261.75 USD
6/17/20261.80 USD
6/16/20261.80 USD
6/15/20261.83 USD
6/12/20261.85 USD
6/11/20261.84 USD
6/10/20261.72 USD
6/9/20261.71 USD
6/8/20261.70 USD
6/5/20261.68 USD
6/4/20261.82 USD
6/3/20261.78 USD
6/2/20262.13 USD
6/1/20262.17 USD
5/29/20262.17 USD
5/28/20262.20 USD
5/27/20262.18 USD
5/26/20262.23 USD
5/22/20262.12 USD
5/21/20262.17 USD
5/20/20262.23 USD
5/19/20262.21 USD
5/18/20262.25 USD
5/15/20262.23 USD
5/14/20262.25 USD
5/13/20262.26 USD
5/12/20262.22 USD
5/11/20262.26 USD
5/8/20262.28 USD
5/7/20262.30 USD
5/6/20262.31 USD
5/5/20262.37 USD
5/4/20262.27 USD
5/1/20262.30 USD
4/30/20262.24 USD
4/29/20262.26 USD
4/28/20262.25 USD
4/27/20262.30 USD
4/24/20262.29 USD
4/23/20262.23 USD
4/22/20262.32 USD
4/21/20262.30 USD
4/20/20262.37 USD
4/17/20262.33 USD
4/16/20262.34 USD
4/15/20262.35 USD
4/14/20262.35 USD
4/13/20262.30 USD
4/10/20262.30 USD
4/9/20262.31 USD
4/8/20262.32 USD
4/7/20262.32 USD
4/6/20262.35 USD
4/2/20262.29 USD
4/1/20262.36 USD
3/31/20262.28 USD
3/30/20262.21 USD
3/27/20262.23 USD
3/26/20262.31 USD
3/25/20262.33 USD
3/24/20262.28 USD
3/23/20262.30 USD
3/20/20262.42 USD
3/19/20262.48 USD
3/18/20262.49 USD
3/17/20262.55 USD
3/16/20262.44 USD
3/13/20262.46 USD
3/12/20262.43 USD
3/11/20262.49 USD
3/10/20262.56 USD
3/9/20262.59 USD
3/6/20262.61 USD
3/5/20262.61 USD
3/4/20262.74 USD
3/3/20262.73 USD
3/2/20262.73 USD
2/27/20262.74 USD
2/26/20262.75 USD
2/25/20262.78 USD
2/24/20262.81 USD
2/23/20262.88 USD
2/20/20262.95 USD
2/19/20263.01 USD
2/18/20263.08 USD
2/17/20263.05 USD
2/13/20263.18 USD
2/12/20262.93 USD
2/11/20262.97 USD
2/10/20262.82 USD
2/9/20262.94 USD
2/6/20262.88 USD
2/5/20262.98 USD
2/4/20263.09 USD
2/3/20263.13 USD
2/2/20263.07 USD
1/30/20263.19 USD
1/29/20263.23 USD
1/28/20263.28 USD
1/27/20263.24 USD
1/26/20263.27 USD
1/23/20263.32 USD
1/22/20263.43 USD
1/21/20263.38 USD
1/20/20263.29 USD
1/16/20263.35 USD
1/15/20263.40 USD
1/14/20263.49 USD
1/13/20263.43 USD
1/12/20263.37 USD
1/9/20263.32 USD
1/8/20263.32 USD
1/7/20263.37 USD
1/6/20263.57 USD
1/5/20263.29 USD
1/2/20263.30 USD
12/31/20253.20 USD
12/30/20253.25 USD
12/29/20253.39 USD
12/26/20253.47 USD
12/24/20253.55 USD
12/23/20253.42 USD
12/22/20253.50 USD
12/19/20253.60 USD
12/18/20253.65 USD
12/17/20253.70 USD
12/16/20253.90 USD
12/15/20252.87 USD
12/12/20252.94 USD
12/11/20252.98 USD
12/10/20251.77 USD
12/9/20251.61 USD
12/8/20251.60 USD
12/5/20251.65 USD
12/4/20251.73 USD
12/3/20251.76 USD
12/2/20251.73 USD
12/1/20251.74 USD
11/28/20251.75 USD
11/26/20251.77 USD
11/25/20251.63 USD
11/24/20251.64 USD
11/21/20251.61 USD
11/20/20251.61 USD
11/19/20251.68 USD
11/18/20251.86 USD
11/17/20251.96 USD
11/14/20252.00 USD
11/13/20251.96 USD
11/12/20252.90 USD
11/11/20252.69 USD
11/10/20252.61 USD
11/7/20252.58 USD
11/6/20252.45 USD
11/5/20252.51 USD
11/4/20252.47 USD
11/3/20252.44 USD
10/31/20252.57 USD
10/30/20252.52 USD
10/29/20252.59 USD
10/28/20252.57 USD
10/27/20252.66 USD
10/24/20252.74 USD
10/23/20252.75 USD
10/22/20252.90 USD
10/21/20252.65 USD
10/20/20252.51 USD
10/17/20252.51 USD
10/16/20252.54 USD
10/15/20252.57 USD
10/14/20252.56 USD
10/13/20252.49 USD
10/10/20252.42 USD
10/9/20252.54 USD
10/8/20252.57 USD
10/7/20252.54 USD
10/6/20252.55 USD
10/3/20252.62 USD
10/2/20252.60 USD
10/1/20252.45 USD
9/30/20252.51 USD
9/29/20252.51 USD
9/26/20252.65 USD
9/25/20252.65 USD
9/24/20252.64 USD
9/23/20252.66 USD
9/22/20252.63 USD
9/19/20252.73 USD
9/18/20252.80 USD
9/17/20252.78 USD
9/16/20252.82 USD
9/15/20252.81 USD
9/12/20252.80 USD
9/11/20252.83 USD
9/10/20252.73 USD
9/9/20252.84 USD
9/8/20252.85 USD
9/5/20253.05 USD
9/4/20253.04 USD
9/3/20253.03 USD
9/2/20253.02 USD
8/29/20253.07 USD
8/28/20253.10 USD
8/27/20253.16 USD
8/26/20253.05 USD
8/25/20253.16 USD
8/22/20253.14 USD
8/21/20253.09 USD
8/20/20253.12 USD
8/19/20253.03 USD
8/18/20253.05 USD
Access this data via the Eulerpool API
Get Free API Key

Petmed Express Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
303.58 M USD
30.53 M USD
23.92 M USD
Jan 1, 2022
273.42 M USD
25.71 M USD
21.10 M USD
Jan 1, 2023
256.58 M USD
6.55 M USD
5.14 M USD
Jan 1, 2024
274.10 M USD
-6.96 M USD
-7.46 M USD
Jan 1, 2025
226.97 M USD
-330,000.00 USD
-6.27 M USD
Jan 1, 2026
179.02 M USD
-31.42 M USD
-57.29 M USD
Jan 1, 2027 (e)
180.32 M USD
-2.59 M USD
1.44 M USD
Jan 1, 2028 (e)
184.40 M USD
-2.65 M USD
1.85 M USD

Petmed Express Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 17, 2026, 11:37 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201320142015201620172018201920202021202220232024202520262027e2028e
227.00233.00229.00234.00249.00273.00283.00284.00303.00273.00256.00274.00226.00179.00180.00184.00
-4.622.64-1.722.186.419.643.660.356.69-9.90-6.237.03-17.52-20.800.562.22
33.9233.0533.1932.4831.7335.5333.5728.5227.7227.4727.7328.1030.5322.3522.3522.35
77.0077.0076.0076.0079.0097.0095.0081.0084.0075.0071.0077.0069.0040.0040.2241.12
27.0028.0027.0032.0037.0052.0046.0030.0030.0025.006.00-6.00–-31.00-2.00-2.00
11.8912.0211.7913.6814.8619.0516.2510.569.909.162.34-2.19–-17.32-1.11-1.09
17.0017.0017.0020.0023.0037.0037.0025.0023.0021.005.00-7.00-6.00-57.001.001.00
6.25––17.6515.0060.87–-32.43-8.00-8.70-76.19-240.00-14.29850.00-101.75–
0.640.680.710.750.791.041.081.111.181.200.901.20––1.291.38
-60.006.254.415.635.3331.653.852.786.311.69-25.0033.33–––6.98
20.0820.1620.2520.4120.4320.4919.9920.1020.3320.3021.1620.6320.6021.0321.0321.03
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Petmed Express generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Petmed Express retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Petmed Express's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Petmed Express has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Petmed Express's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Petmed Express stock margins

The Petmed Express margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Petmed Express. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Petmed Express.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
27.77 %
10.06 %
7.88 %
Jan 1, 2022
27.55 %
9.40 %
7.72 %
Jan 1, 2023
27.68 %
2.55 %
2.00 %
Jan 1, 2024
28.35 %
-2.54 %
-2.72 %
Jan 1, 2025
30.46 %
-0.15 %
-2.76 %
Jan 1, 2026
22.81 %
-17.55 %
-32.00 %
Jan 1, 2027 (e)
22.81 %
-1.44 %
0.80 %
Jan 1, 2028 (e)
22.81 %
-1.44 %
1.01 %

Petmed Express Stock Revenue, EBIT, Earnings per Share

The Petmed Express earnings per share therefore indicates how much revenue Petmed Express has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
14.93 USD
1.50 USD
1.18 USD
Jan 1, 2022
13.47 USD
1.27 USD
1.04 USD
Jan 1, 2023
12.13 USD
0.31 USD
0.24 USD
Jan 1, 2024
13.28 USD
-0.34 USD
-0.36 USD
Jan 1, 2025
11.02 USD
-0.02 USD
-0.30 USD
Jan 1, 2026
8.51 USD
-1.49 USD
-2.72 USD
Jan 1, 2027 (e)
8.76 USD
-0.12 USD
0.07 USD
Jan 1, 2028 (e)
8.95 USD
-0.13 USD
0.09 USD

Petmed Express business model & stock analysis

Petmed Express Inc. is a US company that was founded in 1996 and is based in Delray Beach, Florida. The company is best known by its trade name - 1800-PetMeds. It is one of the largest online pharmacies for pet supplies and offers a variety of products such as medications, supplements, food, toys, and accessories for pets. The company's history is rooted in the emergence of online commerce. In 1996, Marc Puleo founded the company when he realized that there was no pharmacy specializing in pet supplies and wanted to capitalize on the potential of the then-new medium - the internet - to build a nationwide company. In the early years, 1800-PetMeds worked hard to bring awareness of the company to consumers and veterinarians through the internet. The company sought and found ways to gain customer trust and differentiate itself from traditional veterinary practices. 1800-PetMeds offered affordable medications and a wide range of pet products. In this way, Petmed Express Inc. became a pioneering company in e-commerce, revolutionizing how veterinarians and their patients gain access to products. Over the years, the company built long-standing business relationships with leading manufacturers of pet products and veterinarians to expand its offerings. 1800-PetMeds' business model is based on a simple concept - providing pet products and medications at lower prices than local veterinarians. The company operates a wide range of platforms that make it easy for users to find the desired product, with user-friendly service features for customers. One of the major advantages for consumers is that they can easily place their orders online or through a phone call. This allows them to have the necessary medications and treatments for their pets directly delivered to their homes, avoiding potential stress factors that a visit to the veterinarian would trigger. Petmed Express offers a wide range of products for pets, including medications for various types of animal diseases and injuries. Special preparations are available for many conditions in the areas of heart, digestion, kidneys and metabolism, skin, as well as anxiety and stress management. In addition, 1800-PetMeds offers subsidized medications for older pets or those with chronic illnesses. In addition to prescription medications and supplements, Petmed Express also offers a wide range of pet supplies. This includes dog food, cat food, treats, toys, beds, grooming and hygiene items. Petmed Express also has a unique program that is not found in e-commerce called the 'Petscription' program. This is a program where members have the advantage of obtaining medications prescribed directly by veterinarians at a lower price than at their local veterinarians. This program is a major competitive advantage for 1800-PetMeds. In recent years, the company has made significant progress in improving accessibility. The establishment of a mobile shopping center in various locations in the US and the program to support animal welfare organizations have promoted the growth of Petmed. Thanks to its decades of experience and numerous partnerships in the animal health industry, Petmed Express has established a solid position in the industry. The company is one of the largest online pharmacies for pets in the US and is known for its dedicated team of professionals who are available 24/7 to assist customers with any questions and concerns. Overall, Petmed Express is an innovative company that has made a name for itself through its business model, wide range of products, and commitment to the protection and health of animals. Petmed Express Inc. has experienced tremendous growth in recent years and remains on track to continue growing and continuing its commitment to animal health and wellbeing.

Petmed Express SWOT Analysis

Strengths

Petmed Express Inc. has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and recognition in the pet medication industry. This reputation has been built through years of providing quality and reliable pet medications and services to its customers. Additionally, Petmed Express Inc. has a wide range of products, offering a comprehensive selection of medications and supplies for pets. This diverse product portfolio allows the company to cater to the varied needs of pet owners.

Weaknesses

Petmed Express Inc. also faces certain weaknesses that may hinder its growth and profitability. One key weakness is the company's limited geographical presence. While Petmed Express Inc. operates nationally, it may not have the same level of reach and accessibility as some of its competitors. Additionally, the company heavily relies on third-party manufacturers and suppliers for its products. This dependence on external sources may lead to potential disruptions in the supply chain or quality control issues.

Opportunities

There are several opportunities for Petmed Express Inc. to explore and expand its business. One significant opportunity is the growing pet ownership and pet healthcare market. As more individuals are adopting pets and becoming pet owners, there is an increased demand for pet medications and related services. By capitalizing on this trend, Petmed Express Inc. can tap into a larger customer base and potentially increase its market share. Additionally, the company can also consider expanding its product offerings to include specialized pet care services, such as grooming or training, to cater to the evolving needs of pet owners.

Threats

Petmed Express Inc. faces various threats that may pose challenges to its operations and position in the market. One major threat is the presence of intense competition in the pet medication industry. There are numerous competitors, including traditional brick-and-mortar stores and online retailers, offering similar products and services. This competitive landscape may lead to price wars and margin pressures. Moreover, the industry is subject to stringent regulations and compliance requirements, which may increase operational costs and create barriers to entry for new players.

Petmed Express Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Petmed Express Employees
Details
Date
Petmed Express Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees
Jan 1, 2026
- Employees

Petmed Express Segments

Petmed Express Revenue by Segment

  • Max

Reportable Segment
Details
Date
Reportable Segment
Jan 1, 2025
226.97 M USD

Petmed Express Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Petmed Express historical P/E ratio, EBIT multiple, and P/S ratio

Petmed Express annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Petmed Express shares outstanding

The number of shares of Petmed Express was 20.6 M in 2025. This indicates how many shares Petmed Express is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
20.33 M Stocks
Jan 1, 2022
20.30 M Stocks
Jan 1, 2023
21.16 M Stocks
Jan 1, 2024
20.63 M Stocks
Jan 1, 2025
20.60 M Stocks
Jan 1, 2026
21.03 M Stocks
Jan 1, 2027 (e)
21.03 M Stocks
Jan 1, 2028 (e)
21.03 M Stocks

Petmed Express stock splits

In Petmed Express's history, there have been no stock splits.

Petmed Express Dividend History

16 years of dividend payments

YearAnnual DividendYoY ChangePayments
20240.60USD↓ 33.3%—
20230.90USD↓ 25.0%3×
20221.20USD↑ 1.7%4×
20211.18USD↑ 6.3%4×
20201.11USD↑ 2.8%4×
20191.08USD↑ 3.8%4×
20181.04USD↑ 31.6%4×
20170.79USD↑ 5.3%4×
20160.75USD↑ 5.6%4×
20150.71USD↑ 4.4%4×

Petmed Express dividend payout ratio

In 2025, Petmed Express had a payout ratio of 227.13%. The payout ratio indicates the percentage of the company's profits that Petmed Express distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
100.29 %
Jan 1, 2022
115.46 %
Jan 1, 2023
370.52 %
Jan 1, 2024
195.42 %
Jan 1, 2025
227.13 %
Jan 1, 2026
264.36 %
Jan 1, 2027 (e)
1,836.69 %
Jan 1, 2028 (e)
1,530.54 %

Current Petmed Express forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
0.00 % (0)
Hold
33.33 % (2)
Sell
66.67 % (4)
12M Price Target
2.81
Last Price
1.83
Currency
USD
12M Return Potential
53.28 %
LTM Return
0 %

Petmed Express Analyst Rating Actions

DateFirmActionRatingReliability
4/17/2025
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60
8/7/2024
Lake Street
Lake Street
DowngradeBuyHold–
6/12/2024
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60
6/12/2024
Lake Street
Lake Street
MaintainedBuy–
11/16/2023
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60
10/31/2023
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60
10/19/2023
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60
7/27/2023
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60
5/25/2023
Lake Street
Lake Street
MaintainedBuy–
3/23/2023
Morgan Stanley
Morgan Stanley
MaintainedUnderweight60

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Petmed Express Earnings Calls

Petmed Express Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/13/20260.12USD--USD-2027 Q1
6/15/2026-0.13USD--USD-2026 Q4
2/9/2026-0.06USD--USD-2026 Q3
8/13/2025-0.06USD--USD-2025 Q4
5/20/20240.14USD-66.74 MUSD-2023 Q4
11/7/20220.26USD-66.53 MUSD-2023 Q2
10/24/20220.35USD-73.53 MUSD-2022 Q2
7/25/20220.26USD-79.43 MUSD-2023 Q1
5/9/20220.27USD-69.15 MUSD-2022 Q4
1/24/20220.31USD-65.07 MUSD-2022 Q3
...

EESG©

Eulerpool ESG Scorecard© for the Petmed Express stock

41/100
6
Environment
35
Social
81
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees69
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Petmed Express shareholder structure

% Name
12.52523%
SilverCape Investments Ltd.
SilverCape Investments Ltd.
12.50243%
Nina Capital Holdings Inc
Nina Capital Holdings Inc
6.52692%
Renaissance Technologies LLC
Renaissance Technologies LLC
4.68077%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
4.01487%
Hotchkis and Wiley Capital Management, LLC
Hotchkis and Wiley Capital Management, LLC
2.62668%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
...

Petmed Express Beneficial Ownership Filings (SEC 13D/G)

Free Float
63.5%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
15.70%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
12.07%
SilverCape Investments Limited
SilverCape Investments Limited
SEC ↗
12.07%
Peter Kennedy
Peter Kennedy
SEC ↗
10.40%
Guven Kivilcim
Guven Kivilcim
SEC ↗
10.08%
Moises Tache Galante
Moises Tache Galante
SEC ↗
10.00%
FMR LLC
FMR LLC
SEC ↗
10.00%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
8.23%
BlackRock for purposes of Schedule 13G filings.
BlackRock for purposes of Schedule 13G filings.
SEC ↗
7.52%
Nina Capital Holdings Inc.
Nina Capital Holdings Inc.
SEC ↗
7.47%
04-2683227
04-2683227
SEC ↗

Petmed Express Executives and Management Board

8 members · avg. age 50 · 50 % women

LC

Ms. Leslie Campbell (67)

Chairman of the Board, President, Interim Chief Executive Officer · since 2018

143,069.00 USD

Management

DK

Mr. Doug Krulik (56)

Interim Chief Financial Officer, Chief Accounting Officer

–
CC

Ms. Caroline Conegliano

Chief Operating Officer

–
US

Mr. Umesh Sripad

Chief Digital and Technology Officer

–
CD

Ms. Carla Dodds

Chief Marketing Officer

–

Board of Directors

PB

Mr. Peter Batushansky (42)

Director

–
JM

Mr. Justin Mennen (43)

Independent Director

–
LS

Ms. Leah Solivan (44)

Independent Director

–

Petmed Express Supply Chain

Petmed Express Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
IZEA Worldwide
Supplier·Interactive Media & Services·US
-0.34
0.69
-0.20
0.47
0.78
0.43

Frequently asked questions about Petmed Express

The business model of Petmed Express Inc. is focused on providing convenient and affordable pet medications and veterinary products directly to pet owners. Petmed Express operates through its website and a toll-free customer service center, allowing customers to easily order prescription and non-prescription medications, as well as other pet supplies. The company also offers free shipping on orders over a certain amount, further enhancing its value proposition to customers. By streamlining the process of obtaining pet medications, Petmed Express aims to offer a cost-effective solution for pet owners, ultimately promoting the health and well-being of their beloved pets.

Petmed Express Inc, commonly known as PetMeds, primarily operates within the pet care industry. As a leading online pet pharmacy, Petmed Express Inc focuses on the distribution of prescription and non-prescription pet medications, as well as other health and wellness products for pets. With its wide range of offerings, Petmed Express Inc serves as a one-stop destination for pet owners seeking convenient access to pet supplies. While primarily active in the pet care sector, Petmed Express Inc contributes to the overall animal health industry by providing medications and products that support the well-being of beloved companions.

The main competitors of PetMed Express Inc in the market include companies like Chewy Inc, 1-800-PetMeds, and Petco Animal Supplies Inc.

Petmed Express Inc, commonly known as PetMeds, is a leading online pet pharmacy in the United States. Established in 1996, PetMeds has a rich history of providing convenient and affordable pet medications and supplies to pet owners across the country. With a focus on delivering exceptional customer service and high-quality products, PetMeds has built a strong reputation in the pet healthcare industry. Over the years, the company has grown exponentially and has become a trusted name among pet owners, offering a wide range of prescription and non-prescription medications, as well as pet accessories and supplements. PetMeds continues to thrive as a reliable online destination for pet health needs.

Petmed Express Inc has achieved several significant milestones throughout its history. The company has consistently delivered quality pet medications and supplies across the United States. It has established a strong presence in the online pet pharmacy market, catering to the increasing demand for convenient and cost-effective pet care products. Petmed Express Inc has diligently grown its customer base and created a loyal following by providing exceptional customer service. The company's commitment to pet health and wellbeing has been recognized through numerous industry awards and accolades. Overall, Petmed Express Inc has successfully carved a niche for itself in the pet pharmaceutical industry, solidifying its position as a reliable and trusted provider of pet medications and related products.

Petmed Express Inc, also known as 1-800-PetMeds, primarily operates in the United States. As a leading provider of pet medications, the company serves customers across all regions and states within the US. With a comprehensive online platform, Petmed Express Inc offers convenient access to a wide range of affordable prescription and over-the-counter pet medications, catering to the needs of pet owners nationwide. By focusing on the US market, Petmed Express Inc has established itself as a trusted and reliable destination for pet medication needs, ensuring the well-being of pets across the country.

Petmed Express Inc represents values of customer-centric service, trust, and quality in the pet medication industry. With a commitment to providing affordable and convenient pet medications, Petmed Express aims to ensure the well-being of pets and satisfaction of their owners. The company's corporate philosophy revolves around delivering exceptional healthcare solutions for pets, emphasizing personalized care and easy accessibility. Petmed Express prioritizes transparency, reliability, and professionalism in all its operations, striving to establish long-term relationships with customers based on trust and ethical practices.

Analysts currently set an average price target of 2.81 USD for the Petmed Express stock (median: 2.81 USD), implying +53.3 % versus the latest price. The consensus is based on 6 analyst ratings.

Petmed Express Analyst Price Targets 2026

6 analysts currently rate the Petmed Express stock: 0 recommend buying, 2 holding and 4 selling.

Petmed Express Analyst Price Targets 2026

Converted at the current exchange rate, the Petmed Express share trades at 1.58 EUR (1.83 USD).

The Petmed Express share (PETS) is listed on 5 stock exchanges, including: NASDAQ (PETS), Frankfurt (PQM.F), München (PQM.MU), Düsseldorf (PQM.DU), SIX (Zürich) (PQM.SW).

Petmed Express Inc is a publicly traded company that has been successfully operating in the online trade of veterinary medicines since 1996. The company is known under the names "PetMeds" and "1800PetMeds". The business model of Petmed Express is based on selling animal medications and products through the internet and phone. Customers have the opportunity to purchase a variety of products for dogs, cats, and other animals, including prescription medications, supplements, vaccines, and other health products. The company focuses on products prescribed by veterinarians. Petmed Express offers its customers a range of benefits, including fast delivery, free shipping on orders over $49.95, a loyalty program, and an easy return and refund policy. The company is also committed to offering customers the best price in the market and regularly provides special offers and discount codes. An important part of Petmed Express' business model is collaborating with veterinarians. They can refer customers to the company and receive a commission in return. The company also works with various animal organizations to support animal welfare and rescue efforts. Petmed Express also has a division called "Vetmedin" that specializes in marketing Vetmedin®, a medication for treating heart failure in dogs. This medication is only available with a prescription, and the company works closely with veterinarians to provide it to affected dogs. Another important aspect of Petmed Express is the brand "Frontline". The company is the exclusive online distribution partner for Frontline® products in the United States. Frontline® is a well-known product for combating fleas and ticks in dogs and cats. Petmed Express is headquartered in Delray Beach, Florida. The company employs around 430 employees and operates a large distribution center in Pompano Beach, Florida. In summary, Petmed Express' business model is focused on the online sale of veterinary medications and products, as well as collaborating with veterinarians. The company offers its customers a wide range of products, fast delivery, free shipping, a loyalty program, and an easy return and refund policy. Additionally, the company works closely with animal organizations and veterinarians to support animal welfare and rescue efforts.

The revenue of Petmed Express is 179.02 M USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Petmed Express is -57.29 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Petmed Express is currently -0.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Petmed Express stock.

The price-to-sales ratio (P/S) of Petmed Express is currently 0.22. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Petmed Express stock.

The Eulerpool Quality Score for Petmed Express is 1/10.

The ISIN of Petmed Express is US7163821066. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Petmed Express is 121843. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Petmed Express is PETS. The ticker symbol is used to trade Petmed Express shares on the stock exchange.

Over the past 12 months, Petmed Express paid a dividend of 0.60 USD . This corresponds to a dividend yield of about 32.79 %. For the coming 12 months, Petmed Express is expected to pay a dividend of 1.29 USD.

The current dividend yield of Petmed Express is 32.79 %.

Petmed Express pays a dividend, distributed in the months of , , , .

Petmed Express paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 1.29 USD are expected. This corresponds to a dividend yield of 70.26 %.

Petmed Express is assigned to the 'Cyclical consumption' sector.

To receive the latest dividend of Petmed Express from amounting to 0.3 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Petmed Express distributed 0.6 USD as dividends.

The dividends of Petmed Express are distributed in USD.

All fundamentals and in-depth analysis of Petmed Express

Our stock analysis for Petmed Express stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Petmed Express. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Petmed Express Stock
Petmed Express Revenue→
Petmed Express Stock
Petmed Express Net Income→
Petmed Express Stock
Petmed Express P/E→
Petmed Express Stock
Petmed Express P/S→
Petmed Express Stock
Petmed Express EBIT→
Petmed Express Stock
Petmed Express Dividend→
Petmed Express Stock
Petmed Express Directors Dealings→
Petmed Express Stock
Petmed Express Stocks→
Petmed Express Stock
Petmed Express Market capitalization→
Petmed Express Stock
Petmed Express Debt→
Petmed Express Stock
Petmed Express Liabilities→
Petmed Express Stock
Petmed Express Equity→
Petmed Express Stock
Petmed Express AAQS→
Petmed Express Stock
Petmed Express Employees→
Petmed Express Stock
Petmed Express ROE→
Petmed Express Stock
Petmed Express ROA→
Petmed Express Stock
Petmed Express ROCE→
Petmed Express Stock
Petmed Express News→
Petmed Express Stock
Petmed Express Analyst Price Targets→

Cyclical consumption Stocks

Petro USAPetgoPets at Home GroupPeter Warren Automotive HoldingsPferdewetten dePetco Health and Wellness CompanyPHA CoPet Valu HoldingsPhilionPersimmonPhilippine Racing ClubPerfect Medical Health ManagementAll Stocks A–Z →